In more detail, EGCG exerts these functions via suppressing the stimulatory effects of STAT1 on SLC7A11 promoter, leading to ferroptosis in A549 cells and restricting tumor growth in vivo [59]. The gene discussed is SLC7A11; the disease is neoplasm.